Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sovcomflot reports for 9 months of 2024 by IFRS

11/15/24 FLOT

Sovcombank reported for the 9 months of 2024 by IFRS

11/15/24 SVCB

Headhunter reported for 9 months of 2024 by IFRS

11/15/24 HEAD

Henderson opened renovated salons in Moscow and Cheboksary

11/15/24 HNFG

TCS Holding shareholders approved the change of name to T-Technologies

11/14/24 TCSG

Shareholders of T-Bank approved dividends

11/14/24 TCSG

Mechel reduced pig iron and steel output by 5%

11/14/24 MTLR

Bank of Russia closes access to any foreign securities other than EAEU to non-qualified persons

11/14/24 MOEX

CarMoney's lending volume grew by 2% at the end of 9 months

11/14/24 CARM

Board of Directors of Tatneft recommended dividends

11/14/24 TATN